![Michael Thompson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Michael C.
Thompson currently works at DICE Therapeutics, Inc., as Treasurer & Director from 2023, Sigilon Therapeutics, Inc., as Treasurer & Director from 2023, and POINT Biopharma Global, Inc., as Treasurer & Director from 2023.
Postes actifs de Michael Thompson
| Sociétés | Poste | Début |
|---|---|---|
| DICE THER | Directeur/Membre du Conseil | 09/08/2023 |
| SIGILON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/08/2023 |
| POIT BIOP | Directeur/Membre du Conseil | 27/12/2023 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology Develops oral immunology and other therapeutic products | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic treatments for chronic diseases | Health Technology |
POINT Biopharma Global, Inc.
 POINT Biopharma Global, Inc. BiotechnologyHealth Technology Develops radioligand therapies for the treatment of cancer | Health Technology |
